Skip to main content

Arena Pharmaceuticals Inc

ARNADelisted Mar 11, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001080709

Arena Pharmaceuticals Inc was delisted on Mar 11, 2022; its insiders filed their last Form 4 on Mar 11, 2022; 317 institutions reported holding it in 13F filings for Q4 2021, worth $4.87B in total; no superinvestor held it.

Holders of 5% or more of ARNA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Arena Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Arena Pharmaceuticals Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Arena Pharmaceuticals Inc, newest first.

No Schedule 13D or 13G filings on Arena Pharmaceuticals Inc are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Arena Pharmaceuticals Inc shares.

No Form 144 notices for Arena Pharmaceuticals Inc are on file.